Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: A 24-week prospective study

Anupam Jena, Ravinder K. Sachdeva, Aman Sharma, Ajay Wanchu

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: A 24-week prospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences